ASHLEMAN ERIC D 4
4 · IDEX CORP /DE/ · Filed May 13, 2026
Research Summary
AI-generated summary of this filing
IDEX CEO Eric Ashleman Exercises Options and Sells Shares
What Happened
Eric D. Ashleman, CEO, President and Director of IDEX Corp (IEX), exercised 15,385 stock options on May 11, 2026 at an exercise price of $93.27 (cost ~$1,434,959) and immediately sold those 15,385 shares in the open market. The sales were in two blocks: 10,470 shares at a weighted average price of $214.95 (proceeds ~$2,250,481) and 4,915 shares at a weighted average price of $215.81 (proceeds ~$1,060,714), for total gross proceeds of about $3,311,195. The Form 4 also shows a derivative disposition of 15,385 shares at $0 consistent with the exercise/conversion reporting.
Key Details
- Transaction date: May 11, 2026 (reported on Form 4 filed May 13, 2026)
- Option exercise: 15,385 shares acquired at $93.27 each — total cost $1,434,959
- Open-market sales: 10,470 shares @ $214.95 (weighted avg) and 4,915 shares @ $215.81 (weighted avg); total proceeds ≈ $3,311,195
- Footnotes: Sales executed in multiple trades. First block traded between $214.425–$215.41 (F1); second block between $215.425–$216.165 (F2). The filer offered to provide per-trade details on request.
- Shares owned after the transaction: not specified in the provided filing excerpt
- Timeliness: Filed May 13 for a May 11 transaction (Form 4 filed within the standard reporting window)
Context
This filing shows an option exercise followed by same-day sales of the resulting shares. That pattern is commonly used to cover the exercise cost and any tax withholding; the Form 4 reflects both the acquisition (exercise) and the subsequent open-market sales. The net effect for the insider was a sale of all 15,385 shares obtained via exercise, producing modest net cash inflow after the exercise cost. As always, insider sales can be routine and do not by themselves indicate company performance changes.
Insider Transaction Report
- Exercise/Conversion
COMMON STOCK
2026-05-11$93.27/sh+15,385$1,434,959→ 82,043 total - Sale
COMMON STOCK
[F1]2026-05-11$214.95/sh−10,470$2,250,481→ 71,573 total - Sale
COMMON STOCK
[F2]2026-05-11$215.81/sh−4,915$1,060,714→ 66,658 total - Exercise/Conversion
OPTIONS (RIGHT TO BUY)
2026-05-11−15,385→ 0 totalExercise: $93.27From: 2018-02-22Exp: 2027-02-22→ COMMON STOCK (15,385 underlying)
Footnotes (2)
- [F1]The transaction was executed in multiple trades at prices ranging from $214.425 to $215.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 1 through 2 of this Form 4.
- [F2]The transaction was executed in multiple trades at prices ranging from $215.425 to $216.165, inclusive.